Identifying Neuro-Glycoproteome Disruption in Congenital Disorders of Glycosylation

I have access to flash frozen cerebellum from a PMM2-CDG individual available at the Children’s Hospital of Philadelphia for glycoproteomic analysis, however, no appropriate control tissue is available. I require control cerebellum tissue to confidently determine changes in glycosite occupancy and glycan structure. I was referred to CBTN by CHOP Pathology who had previously helped in collection of CBTN biobank specimens. I am seeking grossly unaffected cerebellum from autopsy specimens to provide appropriate controls for my PMM2-CDG affected cerebellum sample. I have not been able to identify other sources of control cerebellum.